Nanako Ushio-Watanabe

Dr. Nanako Ushio-Watanabe

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2023 in Redox Biology
Verified
Journal Article
Open access
KYKazuhisa Yamada
Kazuhisa Yamada
ATAkira Tazaki
Akira Tazaki
NUNanako Ushio-Watanabe
Nanako Ushio-Watanabe
Yoshihiko UsuiYoshihiko Usui
Yoshihiko Usui
ATAtsunobu Takeda
Atsunobu Takeda
HKHiroki Kaneko
Hiroki Kaneko
Toxoplasmosis is a major infectious disease, affecting approximately one-third of the world's population; its main clinical manifestation, ocular toxoplasmosis (OT), is a severe sight-threatening disease. Nevertheless, the diagnosis of OT is based on clinical findings, which needs improvement, even with biochemical tests, such as polymerase chain reaction and antibody detections. Furthermore, the efficacy of OT-targeted treatment is limited; thus, additional measures for diagnosis and treatments are needed. Here, we for the first time report a significantly reduced iron concentration in the vitreous humor (VH) of human patients infected with OT. To obtain further insights into molecular mechanisms, we established a mouse model of T. gondii infection, in which intravitreally injected tracer 57Fe, was accumulated in the neurosensory retina. T. gondii-infected eyes showed increased lipid peroxidation, reduction of glutathione peroxidase-4 expression and mitochondrial deformity in the photoreceptor as cristae loss. These findings strongly suggest the involvement of ferroptotic process in the photoreceptor of OT. In addition, deferiprone, an FDA-approved iron chelator, reduced the iron uptake but also ameliorated toxoplasma-induced retinochoroiditis by reducing retinal inflammation. In conclusion, the iron levels in the VH could serve as diagnostic markers and iron chelators as potential treatments for OT.

29 February 2024 in Vaccine
Verified
Journal Article
Closed access
THTanjila Hasan
Tanjila Hasan
NSNaomi Shimoda
Naomi Shimoda
SNShu Nakamura
Shu Nakamura
BFBarbara A. Fox
Barbara A. Fox
DBDavid Bzik
David Bzik
YNYoshifumi Nishikawa
Yoshifumi Nishikawa

12 November 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
KUKousuke Umeda
Kousuke Umeda
YGYouta Goto
Youta Goto
KWKen-ichi Watanabe
Ken-ichi Watanabe
NUNanako Ushio-Watanabe
Nanako Ushio-Watanabe
Ragab FereigRagab Fereig
Ragab Fereig
YNYoshifumi Nishikawa
Yoshifumi Nishikawa
The obligate intracellular parasite Toxoplasma gondii infects warm-blooded animals, including humans. We previously revealed through a whole-brain transcriptome analysis that infection with T. gondii in mice causes immune response-associated genes to be upregulated, for instance, chemokines and chemokine receptors such as CXC chemokine receptor 3 (CXCR3) and its ligand CXC chemokine ligand 10 (CXCL10). Here, we describe the effect of CXCR3 on responses against T. gondii infection in the mouse brain. In vivo assays using CXCR3-deficient mice showed that the absence of CXCR3 delayed the normal recovery of body weight and increased the brain parasite burden, suggesting that CXCR3 plays a role in the control of pathology in the brain, the site where chronic infection occurs. Therefore, to further analyze the function of CXCR3 in the brain, we profiled the gene expression patterns of primary astrocytes and microglia by RNA sequencing and subsequent analyses. CXCR3 deficiency impaired the normal upregulation of immune-related genes during T. gondii infection, in astrocytes and microglia alike. Collectively, our results suggest that the immune-related genes upregulated by CXCR3 perform a particular role in controlling pathology when the host is chronically infected with T. gondii in the brain.

22 August 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
NUNanako Ushio-Watanabe
Nanako Ushio-Watanabe
RFRio Fujihara
Rio Fujihara
KWKen-ichi Watanabe
Ken-ichi Watanabe
MYManabu Yamada
Manabu Yamada
YKYoshiyasu Kobayashi
Yoshiyasu Kobayashi
YNYoshifumi Nishikawa
Yoshifumi Nishikawa
Neospora caninum, as well as Toxoplasma gondii, secrete proteins that facilitate the invasion of host cells and the regulation of host immune response and metabolism. However, the localization of the secretory proteins in infected animal brains has not been studied in detail. Here, we investigate the brain and intracellular distribution of the secretory proteins in experimentally infected mice and naturally infected calves through histopathology and immunohistochemistry (IHC) to detect surface antigen 1 (NcSAG1), cyclophilin (NcCYP), profilin (NcPF), dense granule protein 6 (NcGRA6), and NcGRA7. These methods revealed that numerous tachyzoites positive for NcSAG1, NcCYP, NcPF, NcGRA6, and NcGRA7 were localized in and around the animals’ necrotic lesions, and NcGRA7 was diffusely observed in the necrotic lesions of the infected mice. Moreover, IHC revealed that NcGRA6 and NcGRA7 were distributed in the cytoplasm of infected neurons around the parasites in the infected mice and calves. This suggests that NcGRA6 and NcGRA7 might be directly related to the alteration of neuronal metabolism and activity, and that NcGRA7 might be related to the formation of necrotic lesions.